Related Experiment Videos
AIDS dementia complex and HIV-1 infection: a view from the clinic
R W Price1, J J Sidtis, B J Brew
1Department of Neurology, University of Minnesota, Minneapolis 55455-0323.
Insights
The AIDS dementia complex (ADC) is a subcortical dementia linked to HIV-1 infection, not opportunistic conditions. This review examines clinical data to understand ADC pathogenesis and its relation to HIV-1.
Area of Science:
- Neuroscience
- Infectious Diseases
- Neurology
Background:
- AIDS dementia complex (ADC) is a neurological syndrome characterized by cognitive, motor, and behavioral deficits.
- The exact cause of ADC is not fully understood, but it is strongly associated with Human Immunodeficiency Virus type 1 (HIV-1) infection.
- It is considered a direct effect of HIV-1 rather than a secondary opportunistic illness.
Purpose of the Study:
- To review clinical information relevant to the pathogenesis of ADC.
- To explore the relationship between ADC and HIV-1 infection.
- To synthesize findings from various studies to elucidate ADC development.
Main Methods:
- Review of clinical characteristics of ADC.
- Analysis of ADC epidemiology and natural history.
- Examination of cerebrospinal fluid analysis, neuroimaging, and pathological findings.
- Assessment of ADC response to antiviral therapy.
Main Results:
- Clinical data suggests ADC is fundamentally linked to HIV-1.
- Studies on ADC's clinical presentation, epidemiology, and natural history provide insights into its pathogenesis.
- Neuroimaging and CSF analysis correlate with pathological findings, aiding understanding.
Conclusions:
- ADC pathogenesis is intrinsically related to HIV-1 infection.
- Clinical and pathological evidence supports a direct role of HIV-1 in ADC development.
- Further research into the clinical aspects of ADC is crucial for understanding its link to HIV-1.
Abstract:
The AIDS dementia complex (ADC) is a clinical syndrome which characteristically presents as a "subcortical dementia" with cognitive, motor and behavioral changes. While the pathogenesis remains puzzling in a number of critical aspects, ADC likely relates in a fundamental way to HIV-1, itself, rather than to a secondary, opportunistic condition. This review focuses on some of the clinical information which bears on the pathogenesis of this syndrome and its relation to HIV-1 infection. This information derives from studies of the clinical character of ADC, its epidemiology and natural history, cerebrospinal fluid analysis, neuroimaging results, clinical correlates of pathological findings and its response to antiviral therapy.